GPT and Decreased liver function: After EGCG treatment, liver dysfunction was significantly improved in both the EGCG-25 (AST 44.8 ± 8.85 U/L, ALT 86.8 ± 12.72 U/L, respectively, p < 0.001) and EGCG-50 groups (AST± 15.13 U/L, ALT 117.6 ± 9.13 U/L, respectively, p < 0.05), as displayed in Figure 4.